9-11-2017

3rd Annual Immunogenicity and Tolerance Seminar

The 3rd annual Immunogenicity and Tolerance Seminar is scheduled for the 9th of November, 2017.
Location: Hilton Apollolaan, Apollolaan 138, Amsterdam

This ​meeting ​will ​focus ​on ​the ​determinants ​of ​immunogenicity ​– ​a ​key ​feature ​of ​effective ​vaccines ​and ​a ​key ​barrier ​to ​success ​in ​the ​clinic ​for ​protein ​therapeutics. ​Conversely, ​tolerance ​induction ​is ​a ​key ​feature ​of ​successful ​protein ​therapeutics, ​while ​suppressing ​immune ​responses ​to ​vaccines. ​The ​reduction ​of ​T ​cell ​epitopes ​and ​introduction ​of ​Treg ​epitopes ​(like ​Tregitopes) ​for ​protein ​therapeutics, ​and ​the ​reverse ​process ​for ​vaccines, ​will ​be ​discussed ​and ​illustrated ​in ​case ​studies. ​

Click Here to Register

Enjoy engaging presentations, case studies and discussions with speakers to include Dr. Annie ​De ​Groot, MD (EpiVax CEO), Marieke ​van ​Ham, PhD (Sanquin), Wim ​Jiskoot, ​PhD (Leiden ​University ​Medical ​Center), Vincent ​Lombardi, ​PhD (Stallergenes), Ab ​Osterhaus, ​PhD (University ​of ​Veterinary ​Medicine ​in ​Hannover, ​Germany), Bram ​Slütter, ​PhD (Leiden ​University) and Jagadeesh ​Bayry (Institut ​National ​de ​la ​Santé ​et ​de ​la ​Recherche ​Médicale ​(INSERM) ​Unité). Food, refreshments and cocktail hour to conclude. Register today to reserve your seat, and discover the positive reputation of our seminar:

“Good combination of talks about determinants of immunogenicity and tolerance. Very well hosted by Annie; made good connections between people in audience Good networking possibilities”

“Wide variety of topics related to immunogenicity, it forces us to go outside of our usual domain of expertise.”

Toon desktop versie